Article
FDA Proudly Announces Its First Approval Of An Interchangeable Biosimilar
On July 28, 2021, the Food and Drug Administration (FDA) announced the approval of the first "interchangeable biosimilar"—in this case Mylan Pharmaceticals Inc.'s Semglee® (insulin glargine-yfgn)...
Squire Patton Boggs LLP
